📰 Cheya Pope News

Cheya Pope News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Cheya Pope. Real-time updates on events, politics, business and more.

Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications

January 4, 2024

KAT6 is an emerging target in hormone sensitive breast tumors and other cancers. Overexpression of KAT6A/B correlates with poor clinical outcomes in patients...

San Antonio United States Menarini Stemline Elcin Barker Ergun Cheya Pope Menarini Industrie Farmaceutiche Riunite

Source: newswire.ca

Menarini Group Presented Initial Safety and Efficacy Data from Phase 1b/2 ELEVATE and ELECTRA Combin

December 11, 2023

ELEVATE and ELECTRA studies were designed with the objective to overcome different treatment resistance mechanisms and enhance patient outcomes with oral-oral combination options.A preliminary analysis of data in the phase 1b part of the ELEVATE trial demonstrates antitumor activity of the combination evaluating ORS...

United States Elcin Barker Ergun Cheya Pope Valeria Speroni Cardi Menarini Group Elacestrant Clinical Development Program

Source: pharmiweb.com

The Menarini Group and its subsidiary Stemline Therapeutics: Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU (Elacestrant) in Metastatic Breast Cancer at ASCO 2023

May 25, 2023

ORSERDU (elacestrant) was approved by the FDA in January 2023 for estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer with

United States Gewinn Nur Valeria Speroni Cardi Cheya Pope Elcin Barker Ergun American Society Of Clinical Oncology

Source: finanznachrichten.de

THE MENARINI GROUP AND ITS SUBSIDIARY STEMLINE THERAPEUTICS: Menarini Group Announces New Data on Elacestrant at 2023 ESMO Breast Cancer Congress and 2023 ASCO Annual Meeting

May 9, 2023

The Menarini Group ("Menarini"), a leading Italian pharmaceutical and diagnostics company, and Stemline Therapeutics ("Stemline"), a wholly-owned subsidiary of the Menarini Group, announced today that

United States Cheya Pope Valeria Speroni Cardi Elcin Barker Ergun Stemline Therapeutics Inc European Medicines Agency